GLP-1 drugs like semaglutide and tirzepatide have rewritten the rules of weight loss and diabetes care, but the story turns ...

New skincare launches target GLP-1 users specific skin issues including sagging, laxity, dryness, and dullness. Experts explain what ingredients to look for.

The GLP-1, which she typically injects weekly (she declines to share which specific brand of medication she uses) has been ...

Northwell Health reports that "Ozempic face" describes the facial changes from rapid weight loss using Ozempic, highlighting ...

GLP-1 medications like Ozempic and Wegovy have surged in popularity, but so have scams targeting people eager to access the ...

GLP-1 medications, originally developed to manage blood sugar in people with Type 2 diabetes, are becoming increasingly popular as treatments for obesity. However, these drugs can come with a hefty ...

Hidradenitis suppurativa is a painful chronic skin condition associated with overweight and obesity. In this retrospective study, patients who started a GLP-1 agonist experienced significant declines ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. The pharmaceutical giant Eli Lilly announced last week that its ...

Nearly half of seniors quit GLP-1 weight-loss drugs within a year. Experts reveal why older Americans abandon medications ...

(NEXSTAR) – The World Health Organization has issued new guidance on the use of popular GLP-1 drugs, like Ozempic, Wegovy, Mounjaro, and Zepbound, to treat the “major global health challenge” of ...

The World Health Organization (WHO) on Monday issued its first-ever global guidelines on the use of GLP-1 medications for treating obesity as a chronic illness. In a press release, the WHO said this ...